FDA to review whether to allow more access to certain peptides
MedicalXpress
|
四月 17, 2026
The U.S. Food and Drug Administration (FDA) will soon review whether certain peptides should be allowed in customized medications made by compounding pharmacies.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗